| Writing Group Member | Employment | Research Grant | Other Research Support | Speakers' Bureau/ Honoraria | Expert Witness | Ownership Interest | Consultant/ Advisory Board | Other |
|---|---|---|---|---|---|---|---|---|
| Henry C. Lee Co-Chair | University of California San Diego | Genentech* | None | None | None | None | American Academy of Pediatrics† | Chiesi USA* |
| Edgardo Szyld | Indiana University | None | None | None | None | None | None | None |
| Emer Finan | Mount Sinai Hospital; University of Toronto | None | None | None | None | None | None | None |
| Jessica Illuzzi | Yale School of Medicine | None | None | None | None | None | None | None |
| Beena D. Kamath-Rayne | American Academy of Pediatrics | None | None | None | None | None | None | None |
| Vishal Kapadia | UT Southwestern | NIH† | None | Masimo* | None | Anishe† | None | None |
| Melissa Mahgoub | American Heart Association | None | None | None | None | None | None | None |
| Susan Niermeyer | University of Colorado | NIH* | None | None | None | None | World Health Organization† | None |
| Stephen Schexnayder | Univ. of Arkansas/ Arkansas Children's Hospital | None | None | None | Love & Kirschenbaum LLLC†; Best and Sharp* | None | American Heart Association† | None |
| Georg M. Schmöelzer | University of Alberta | Canadian Institute of Health Research†* | None | None | None | RETAIN Labs Medical* | American Academy of Pediatrics† | None |
| Marya L. Strand | Akron Children's Hospital | Mayo Clinic* | None | None | None | None | None | None |
| Jessica Weglarz | American Academy of Pediatrics | None | None | None | None | None | None | None |
| Gary M. Weiner | University of Michigan | None | None | None | None | None | None | None |
| Amanda L. Williams | Cedars Sinai | None | None | None | None | None | None | Stryker Corporation |
| Myra Wyckoff | UT Southwestern | None | None | None | None | None | None | None |
| Nicole K. Yamada | Stanford University | None | None | None | None | None | None | None |
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $5000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $5000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
*Modest.
†Significant.